SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 203 filers reported holding SAGE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86,777,526 | -58.3% | 4,216,595 | -4.7% | 0.00% | -66.7% |
| Q2 2023 | $208,026,167 | +0.6% | 4,424,206 | -10.3% | 0.01% | 0.0% |
| Q1 2023 | $206,853,821 | +10.5% | 4,929,786 | +0.4% | 0.01% | 0.0% |
| Q4 2022 | $187,281,170 | -0.8% | 4,910,361 | +1.8% | 0.01% | 0.0% |
| Q3 2022 | $188,833,000 | +37.8% | 4,822,063 | +13.7% | 0.01% | +50.0% |
| Q2 2022 | $137,010,000 | +50.3% | 4,241,813 | +54.0% | 0.00% | +100.0% |
| Q1 2022 | $91,163,000 | -22.9% | 2,754,216 | -0.9% | 0.00% | -33.3% |
| Q4 2021 | $118,237,000 | -7.2% | 2,779,437 | -3.3% | 0.00% | -25.0% |
| Q3 2021 | $127,371,000 | -21.3% | 2,874,555 | +0.8% | 0.00% | -20.0% |
| Q2 2021 | $161,938,000 | -34.7% | 2,850,498 | -13.9% | 0.01% | -28.6% |
| Q1 2021 | $247,834,000 | -1.6% | 3,311,068 | +13.8% | 0.01% | -12.5% |
| Q4 2020 | $251,767,000 | +37.6% | 2,910,270 | -2.8% | 0.01% | +14.3% |
| Q3 2020 | $182,985,000 | +38.2% | 2,993,856 | -6.0% | 0.01% | +40.0% |
| Q2 2020 | $132,447,000 | +67.9% | 3,185,313 | +16.0% | 0.01% | +25.0% |
| Q1 2020 | $78,891,000 | -60.8% | 2,746,917 | -1.4% | 0.00% | -50.0% |
| Q4 2019 | $201,066,000 | -48.3% | 2,785,248 | +0.5% | 0.01% | -50.0% |
| Q3 2019 | $388,700,000 | -22.8% | 2,770,699 | +0.8% | 0.02% | -27.3% |
| Q2 2019 | $503,261,000 | +18.4% | 2,748,713 | +2.8% | 0.02% | +15.8% |
| Q1 2019 | $425,216,000 | +76.8% | 2,673,467 | +6.5% | 0.02% | +58.3% |
| Q4 2018 | $240,480,000 | -39.6% | 2,510,491 | -10.9% | 0.01% | -29.4% |
| Q3 2018 | $397,818,000 | -9.0% | 2,816,410 | +0.9% | 0.02% | -15.0% |
| Q2 2018 | $437,116,000 | -28.1% | 2,792,548 | -26.0% | 0.02% | -31.0% |
| Q1 2018 | $607,923,000 | +7.2% | 3,774,283 | +9.6% | 0.03% | +7.4% |
| Q4 2017 | $567,290,000 | +207.8% | 3,444,171 | +16.4% | 0.03% | +200.0% |
| Q3 2017 | $184,286,000 | -23.7% | 2,958,036 | -2.4% | 0.01% | -30.8% |
| Q2 2017 | $241,431,000 | +18.6% | 3,031,548 | +5.9% | 0.01% | +18.2% |
| Q1 2017 | $203,482,000 | +14070.1% | 2,863,124 | +10082.5% | 0.01% | +450.0% |
| Q4 2016 | $1,436,000 | -23.0% | 28,118 | -30.5% | 0.00% | -33.3% |
| Q3 2016 | $1,864,000 | +262.6% | 40,486 | +137.3% | 0.00% | +200.0% |
| Q2 2016 | $514,000 | +1672.4% | 17,064 | +1802.3% | 0.00% | – |
| Q1 2016 | $29,000 | +38.1% | 897 | +152.0% | 0.00% | – |
| Q4 2015 | $21,000 | +61.5% | 356 | +16.3% | 0.00% | – |
| Q3 2015 | $13,000 | -40.9% | 306 | 0.0% | 0.00% | – |
| Q2 2015 | $22,000 | +214.3% | 306 | +120.1% | 0.00% | – |
| Q1 2015 | $7,000 | -97.3% | 139 | -98.1% | 0.00% | – |
| Q4 2014 | $261,000 | +20.3% | 7,139 | +3.5% | 0.00% | – |
| Q3 2014 | $217,000 | – | 6,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |